Skip to content

HbA1c screening in Salzburg pharmacies: data analysis followed by a follow-up survey

HbA1c screening in Salzburg pharmacies: data analysis followed by a follow-up survey

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039393
Enrollment
3000
Registered
2026-02-19
Start date
2026-02-17
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achievability of lifestyle changes in patients with high HbA1c levels

Interventions

Group 1: Arm 1: Volunteers aged 18 and over who are participating in the HbA1c study. From November 10, 2025, to November 15, 2025, HbA1c tests were carried out in pharmacies in Salzburg. The aim was

Sponsors

Paracelsus Medizinische Universität
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals aged 18 and over who participated in routine HbA1c screening at a pharmacy in Salzburg in November 2025 and consent to make their data available for scientific purposes.

Exclusion criteria

Exclusion criteria: Minors, persons without consent, or people with cognitive impairments that make participation difficult.

Design outcomes

Primary

MeasureTime frame
Measurement results of the test subjects during the 7-day action week. The data is collected using specially designed questionnaires.

Secondary

MeasureTime frame
Participants with elevated levels are asked about their willingness to make lifestyle changes and whether they have actually implemented them. Follow-up is conducted via telephone interviews.

Countries

Austria

Contacts

Public ContactOlaf Rose

Paracelsus Medizinische Privatuniversität

infopoint@pmu.ac.at+49 151 54772969

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026